LaurenEAbreyMD

Neurology • New York, NY

Neurologist at Memorial Sloan-Kettering Cancer Center

Join to view full profile

Are you Dr. Abrey?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1275 York Ave
New York, NY 10065
Phone+1 646-227-3813

Summary

Dr. Lauren Abrey, MD is a board certified neurologist in New York, New York. She is currently licensed to practice medicine in New York.

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Neurology, 1992 - 1994
Emory University School of MedicineResidency, Neurology, 1991 - 1992
Providence HospitalInternship, Internal Medicine, 1990 - 1991
Georgetown University School of MedicineClass of 1990

Certifications & Licensure

NY State Medical License 1995 - 2026
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma Start of enrollment: 1998 Sep 01
Completed
Phase 2
Temozolomide in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 1999 Jun 01
Completed
Phase 2
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases Start of enrollment: 2001 Jul 01
Completed
Phase 1, Phase 2
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 2001 Nov 01
Completed
Phase 1
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma Start of enrollment: 2002 Aug 01
Completed
Phase 1, Phase 2
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma Start of enrollment: 2004 Dec 01
Completed
Not Applicable
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer Start of enrollment: 2004 Mar 01
Completed
Phase 1, Phase 2
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma Start of enrollment: 2005 Sep 01
Terminated
Phase 2
Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma Start of enrollment: 2007 Mar 01
Completed
Phase 2
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Start of enrollment: 2007 Oct 01
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2009 Jul 10
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

38 citations
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)
Patrick Y. Wen, Timothy F. Cloughesy, Benjamin M. Ellingson, David A. Reardon, Howard A. Fine
Neuro-Oncology. 2014-10-01
11 citations
CNS Anticancer Drug Discovery and Development: 2016 conference insights
Victor A. Levin, Lauren E. Abrey, Timothy P. Heffron, Peter J. Tonge, Arvin C. Dar
CNS Oncology. 2017-07-18
110 citations
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Patrick Y. Wen, W. K. Alfred Yung, Kathleen R. Lamborn, Andrew D. Norden, Timothy F. Cloughesy
Neuro-Oncology. 2009-12-01